Biomarkers Market is Expected Exceed US$ 60.0 Billion by 2023
The main driving factors for biomarkers market are increase in number of low cost for conducting clinical trials in developing countries. Rising healthcare expenditure and R&D funding are the major macro drivers of the market. The use of biomarkers in diagnostic process is increasing rapidly due to its more accurate results. The biomarkers also have some restraints such as it contain technical issues related to sample and storage. The testing cost of biomarkers is high. It contains high investment but relatively low cost and benefit ratio.Browse Full Report @: https://www.marketresearchengine.com/reportdetails/biomarkers-market
How Big is the Global Biomarkers Market?
The Biomarkers market is expected to exceed more than US$ 60.0 billion by 2023 growing at around 13% CAGR.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include QIAGEN N.V. (Netherlands), PerkinElmer, Inc., Merck & Co, Inc., Bio-Rad Laboratories , Enzo Biochem , EKF Diagnostics Holdings plc , Meso Scale Diagnostics, LLC , Singulex, Inc. , BioSims Technologies , Cisbio Bioassays , and Signosis, Inc.. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
Table of Contents
1 INTRODUCTION
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Biomarkers Market, By Product
7 Biomarkers Market, By Type
8 Biomarkers Market, By Application
9 Biomarkers Market, By Disease Indication
10 Biomarkers Market, By Region
11 Competitive Landscape
12 Company Profiles
12.1 Qiagen N.V.
12.2 Perkinelmer, Inc.
12.3 Merck Millipore
12.4 Bio-Rad Laboratories, Inc.
12.5 Enzo Biochem, Inc.
12.6 EKF Diagnostics Holdings, Inc.
12.7 Meso Scale Diagnostics, LLC.
12.8 Biosims Technologies Sas
12.9 Cisbio Bioassays
12.10 Signosis, Inc.
About MarketResearchEngine.com
Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.
Media Contact
Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Website: https://www.marketresearchengine.com/
Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biomarkers Market is Expected Exceed US$ 60.0 Billion by 2023 here
News-ID: 608550 • Views: …
More Releases from Market Research Engine Reports - MRE
Medical Image Analysis Software Market is Expected to Exceed US$ 3.3 Billion by …
The global medical image analysis software market by software type is segmented as integrated software and standalone software. According to its image types the market is further segmented in to 2D, 3D and 4D imaging. The market is further segmented according to its modality such as tomography, ultrasound imaging, radiography imaging and combined modalities. The application segment consists of orthopedic, dental, neurology, cardiology, oncology, obstetrics and gynecology, mammography and urology…
Pharmacovigilance Market will Rise at a CAGR of 13% During the Forecast, by 2020
The global pharmacovigilance market according to clinical trial phase is segmented aspre-clinical, Phase I, Phase II, Phase IIIandPhase IV. The type of service provider segment consists of In-House and contract outsourcing. The market segments in terms of geographical regions include North America, Europe, Asia-Pacific and Rest of the World(ROW).
Browse Full Report @: https://www.marketresearchengine.com/reportdetails/pharmacovigilance-market
How Big is the Global Pharmacovigilance Market?
Global pharmacovigilance market was valued USD 2.5 billion in 2014. The revenue…
Automated External Defibrillator Market is Expected to Reach US$ 15 Billion by 2 …
The Global Automated External Defibrillator Market is segmented on the lines of its type, end user and regional. Based on type segmentation it covers semi automated external defibrillator and fully automated external defibrillator. Under end user segmentation it covers home based, hospitals and pre hospitals.
Browse Full Report @: https://www.marketresearchengine.com/reportdetails/automated-external-defibrillator-market
How Big is the Global Automated External Defibrillator?
The Global Automated External Defibrillator Market is expected to exceed more than US$ 15…
Neuromodulation Market is Expected to Reach US$ 11 Billion by 2022
The Global Neuromodulation Market is segmented on the lines of its technology, application and biomaterial. Technology segmentation is further classified into internal neuromodulation and external neuromodulation. Based on internal neuromodulation segmentation it covers deep brain stimulation, spinal cord stimulation, vagus nerve stimulation, sacral nerve stimulation and other neuromodulation technologies. External neuromodulation is classified into transcranial magnetic stimulation and transcutaneous electrical nerve stimulation. Based on application segmentation it covers chronic pain…
More Releases for Biomarkers
Predisposition Biomarkers Market - Rapid Growth at Deep Value Price from 2020-20 …
"The new report has been added by qyresearch.com to provide detailed insight into the global Predisposition Biomarkers market. The study will help to get a better understanding about the Predisposition Biomarkers industry competitors, a channel for the distribution, Predisposition Biomarkers growth potential, potentially disruptive trends, Predisposition Biomarkers industry product innovations, market size value/volume (regional/country level, Predisposition Biomarkers industry segments), market share of top players/products.
Due to the pandemic, we have included…
3rd World Biomarkers Summit
We cordially invite you to the 3rd World Biomarkers Summit to be held at Rome, Italy on April 22-23, 2020. The 2020 edition of the Biomarkers conference will move forward with the theme “Biomarker as a future protagonist”. Biomarkers 2020 concentrates on procuring emerging researches in the sector of medicine and health brought to us via applications of biomarkers. Scientists, Young researchers, pharmaceutical industrialists and medical professionals are expected to…
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular…
Global Companion Diagnostic Cancer Biomarkers Market by types (Protein Biomarker …
Global Companion Diagnostic Cancer Biomarkers Market Research Report” Purchase This Report by calling ResearchnReports.com at +1-888-631-6977.
The report, titled Companion Diagnostic Cancer Biomarkers presents an in-depth study of the Companion Diagnostic Cancer Biomarkers market. Providing a brief history about the market, the report analyses the entire value chain of the market and points out the key drivers and restraints affecting the growth of the market during the forecast period. The report…
Global Biomarkers Market Propelled by Growing Usage of Biomarkers in Medical Are …
A biomarker refers to a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures, and biological procedures. Also known as a molecular marker or signature molecule, biomarkers are found in blood, other body fluids, and tissue. Extensively used to see the body’s response to a particular treatment for a disease or condition, biomarkers assist medical professionals to take effective clinical decisions and help…
Biomarkers Summit
SMi present their 4th annual conference on
Biomarkers Summit
Monday 31st January & Tuesday 1st February 2011
Crowne Plaza The-City, London, UK
Don’t Miss Out - Visit to register your place today
http://www.smi-online.co.uk/preclinical-biomarkers.asp
Sponsored by
Caprotec
Cell Signalling Technology
GVK Bio
Selventa
Millipore Quest Diagnostics
RBM
SMi’s highly anticipated 4th annual Biomarkers Summit is fast approaching, and time is running out…